MK-8666

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8666, covering 2016-12-08 to 2016-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003) [Phase 1]

See pricing